APA

Bonnefond A., Yengo L., Philippe J., Dechaume A., Ezzidi I., Vaillant E., Gjesing A. P., Andersson E. A., Czernichow S., Hercberg S., Hadjadj S., Charpentier G., Lantieri O., Balkau B., Marre M., Pedersen O., Hansen T., Froguel P. & Vaxillaire M. (20130819). Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes. : Diabetologia.

Chicago

Bonnefond A, Yengo L, Philippe J, Dechaume A, Ezzidi I, Vaillant E, Gjesing A P, Andersson E A, Czernichow S, Hercberg S, Hadjadj S, Charpentier G, Lantieri O, Balkau B, Marre M, Pedersen O, Hansen T, Froguel P and Vaxillaire M. 20130819. Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes. : Diabetologia.

Harvard

Bonnefond A., Yengo L., Philippe J., Dechaume A., Ezzidi I., Vaillant E., Gjesing A. P., Andersson E. A., Czernichow S., Hercberg S., Hadjadj S., Charpentier G., Lantieri O., Balkau B., Marre M., Pedersen O., Hansen T., Froguel P. and Vaxillaire M. (20130819). Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes. : Diabetologia.

MLA

Bonnefond A, Yengo L, Philippe J, Dechaume A, Ezzidi I, Vaillant E, Gjesing A P, Andersson E A, Czernichow S, Hercberg S, Hadjadj S, Charpentier G, Lantieri O, Balkau B, Marre M, Pedersen O, Hansen T, Froguel P and Vaxillaire M. Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes. : Diabetologia. 20130819.